OpenURL Connection Search

Select item for more details and to access through your institution.

Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis.
Published in:
2020
By:
- Chen, Sijia;
- Blijdorp, Iris C.;
- van Mens, Leonieke J. J.;
- Bowcutt, Rowann;
- Latuhihin, Talia E.;
- de Sande, Marleen G. H. van;
- Shaw, Stevan;
- Yeremenko, Nataliya G.;
- Baeten, Dominique L. P.;
- van de Sande, Marleen G H
Publication type:
journal article
Expansion of Interleukin‐22– and Granulocyte–Macrophage Colony‐Stimulating Factor–Expressing, but Not Interleukin‐17A–Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis
Published in:
Arthritis & Rheumatology, 2019, v. 71, n. 3, p. 392, doi. 10.1002/art.40736
By:
- Blijdorp, Iris C. J.;
- Menegatti, Silvia;
- Mens, Leonike J. J.;
- Sande, Marleen G. H.;
- Chen, Sijia;
- Hreggvidsdottir, Hulda S.;
- Noordenbos, Troy;
- Latuhihin, Talia E.;
- Bernink, Jochem H.;
- Spits, Hergen;
- Rogge, Lars;
- Baeten, Dominique L. P.;
- Yeremenko, Nataliya G.
Publication type:
Article
Brief Report: Interleukin‐17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses.
Published in:
Arthritis & Rheumatology, 2018, v. 70, n. 12, p. 1994, doi. 10.1002/art.40581
By:
- Mens, Leonieke J. J.;
- Sande, Marleen G. H.;
- Menegatti, Silvia;
- Chen, Sijia;
- Blijdorp, Iris C. J.;
- Jong, Henriette M.;
- Fluri, Inka A.;
- Latuhihin, Talia E.;
- Kuijk, Arno W. R.;
- Rogge, Lars;
- Yeremenko, Nataliya G.;
- Baeten, Dominique L. P.
Publication type:
Article

Found: 3

Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis.

Expansion of Interleukin‐22– and Granulocyte–Macrophage Colony‐Stimulating Factor–Expressing, but Not Interleukin‐17A–Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis

Brief Report: Interleukin‐17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses.